As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

An investigation ensued to determine the cause of death. 1 Autopsy findings included no observable signs of external trauma, ...

Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for PT-141 ...

A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...

The process of drug discovery encompasses a variety of methods, including experimental, computational, translational, and clinical.  When successful, | Cancer ...

Method selection hinges on volatility: fluorinated tails weaken intermolecular forces and favor GC, while carboxylate/sulfonate heads suppress volatility and often require LC in ionized form. DHS-TD ...

The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...

Your talk at ASMS was on “PeptDeepKontext: A Universal Model for Predicting Peptide Properties Across Instruments, Conditions ...

Pharmaceutical and biopharmaceutical laboratories increasingly need to characterize complex samples that contain APIs, ...

The AI revolution has begun. Position yourself on the leading edge of artificial intelligence education with master’s-level expertise in the most powerful technologies reshaping our world. The ...

Introduction By 2050, two-thirds of people with dementia will live in low-and-middle-income countries (LMICs). However, multimodal prevention lifestyle interventions for people at risk are being ...